Section 17 Neuromuscular blocking agentsF1
United Kingdom
A person must not use a neuromuscular blocking agent in the course of a regulated procedure unless—
the person is expressly authorised to do so by the personal licence and the project licence under which the procedure is carried out; and
the agent is used in combination with such level of anaesthesia or analgesia as is determined in accordance with the project licence.
The Secretary of State must not grant a project licence that authorises the use of a neuromuscular blocking agent unless the Secretary of State is satisfied, on the basis of a scientific justification, that the purposes of the programme of work specified in the licence cannot be achieved without the use of such an agent.
Annotations
Textual amendments
- F1
S. 17 substituted (1.1.2013) by The Animals (Scientific Procedures) Act 1986 Amendment Regulations 2012 (S.I. 2012/3039), regs. 1(2), 17 (with Sch. 3)